These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 17386879)

  • 1. The rationale and indications for angiotensin receptor blockers in heart failure.
    Bybee KA; Das S; O'Keefe JH
    Heart Fail Clin; 2006 Jan; 2(1):81-8. PubMed ID: 17386879
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of the renin-angiotensin system in cardiovascular protection: Is it important to watch your C'ARB' intake?
    Strauss MH; Verma S
    Can J Cardiol; 2005 May; 21(7):577-80. PubMed ID: 15940355
    [No Abstract]   [Full Text] [Related]  

  • 3. ARBs vs ACE inhibitors for preventing diabetic nephropathy.
    Greenwood V
    J Fam Pract; 2005 May; 54(5):453; discussion 453-4. PubMed ID: 15865904
    [No Abstract]   [Full Text] [Related]  

  • 4. CHARM study in CHF patients with impaired LV function reinforces benefits of candesartan cilexetil (Atacand).
    Cardiovasc J S Afr; 2004; 15(5):252. PubMed ID: 15483738
    [No Abstract]   [Full Text] [Related]  

  • 5. Sex differences in the effectiveness of angiotensin receptor blockers and angiotensin converting enzyme inhibitors in patients with congestive heart failure--a population study.
    Hudson M; Rahme E; Behlouli H; Sheppard R; Pilote L
    Eur J Heart Fail; 2007; 9(6-7):602-9. PubMed ID: 17383932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diastolic heart failure -- a disease of the elderly].
    Witthaut R
    Dtsch Med Wochenschr; 2005 Mar; 130(12):704-9. PubMed ID: 15776355
    [No Abstract]   [Full Text] [Related]  

  • 7. Have angiotensin receptor blockers lived up to expectations?
    Fitchett D
    Can J Cardiol; 2005 May; 21(7):569-75. PubMed ID: 15940354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure: an observational study of treatment rates and clinical outcome.
    Gotsman I; Rubonivich S; Azaz-Livshits T
    Isr Med Assoc J; 2008 Mar; 10(3):214-8. PubMed ID: 18494235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Warning on diuretic use.
    Grundtvig M; Westheim A; Hole T; Flønaes B; Gullestad L;
    J Am Coll Cardiol; 2010 Jun; 55(23):2609-10; author reply 2610. PubMed ID: 20513605
    [No Abstract]   [Full Text] [Related]  

  • 10. Sex differences in response to chronic heart failure therapies.
    Ghali JK; Lindenfeld J
    Expert Rev Cardiovasc Ther; 2008 Apr; 6(4):555-65. PubMed ID: 18402544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progression of chronic kidney disease: can it be prevented or arrested?
    Malani AK; Ammar H; Yassin MH
    Am J Med; 2007 Mar; 120(3):e29; author reply e31. PubMed ID: 17349429
    [No Abstract]   [Full Text] [Related]  

  • 12. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
    Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Drug treatment of heart failure].
    Kettunen R
    Duodecim; 2005; 121(11):1239-48. PubMed ID: 15999983
    [No Abstract]   [Full Text] [Related]  

  • 14. Combined renin-angiotensin-aldosterone system inhibition in patients with chronic heart failure secondary to left ventricular systolic dysfunction.
    Gradman AH; Papademetriou V
    Am Heart J; 2009 Jun; 157(6 Suppl):S17-23. PubMed ID: 19450720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [ELITE II. AT1-blockers not better, but more tolerable than ACE-inhibitors].
    Berger D
    Internist (Berl); 2000 Jan; 41(1):A37. PubMed ID: 10712087
    [No Abstract]   [Full Text] [Related]  

  • 16. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: what to do if the serum creatinine and/or serum potassium concentration rises.
    Palmer BF
    Nephrol Dial Transplant; 2003 Oct; 18(10):1973-5. PubMed ID: 13679467
    [No Abstract]   [Full Text] [Related]  

  • 17. Current possibilities of ACE inhibitor and ARB combination in arterial hypertension and its complications.
    Kolasinska-Malkowska K; Filipiak KJ; Gwizdala A; Tykarski A
    Expert Rev Cardiovasc Ther; 2008 Jun; 6(5):759-71. PubMed ID: 18510491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical inquiries. Are there big differences among beta-blockers in treating essential hypertension?
    Sontheimer D; Hitchcock K; Saseen J
    J Fam Pract; 2007 Apr; 56(4):312-4. PubMed ID: 17403332
    [No Abstract]   [Full Text] [Related]  

  • 19. Underuse of evidence-based therapies.
    Hlatky MA
    Circulation; 2004 Aug; 110(6):644-5. PubMed ID: 15302805
    [No Abstract]   [Full Text] [Related]  

  • 20. [Beginning therapy of heart failure with beta blockers. Do these patients survive longer?].
    MMW Fortschr Med; 2005 Sep; 147(39):10. PubMed ID: 16245769
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.